News · Vaccines
595 stories
Oct 9, 26‘We’re getting back to stability’: CBER Director Karim Mikhail shares his strategy with Fierce
Oct 9, 26Opinion: 50 years ago, my colleagues and I pursued basic research science that became revolutionary
Oct 6, 26Opinion: Infectious disease expert: The mysterious pneumonia in Russia deserves attention, not panic
Oct 6, 26MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’
Oct 5, 26STAT+: Divergent trial results on cancer vaccines have the field grappling with hard questions
Oct 5, 26Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots